• Alberti KG, Zimmet P., Shaw J.. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366: 10591062.
  • Basu R., Man Dalla C., Campioni M., Basu A., Nair KS, Jensen MD, Khosla S., Klee G., Toffolo G., Cobelli C., Rizza RA. Effects of two years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance and postprandial glucose turnover in elderly men. Diabetes Care. 2007;30: 19721978.
  • Chubb SA, Hyde Z., Almeida OP, Flicker L., Norman PE, Jamrozik K., Hankey GJ, Yeap BB. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study. Eur J Endocrinol. 2008;158: 78592.
  • Ding EL, Song Y., Malik VS, Liu S.. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295: 12881299.
  • Gooren LJ, Bunck MC. Androgen replacement therapy: present and future. Drugs. 2004;64: 18611891.
  • Grundy SM, Brewer HB Jr, Cleeman JI, Smith SCJr, Lenfant C., American Heart Association National Heart Lung and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109: 433438.
  • Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006;97: 3A11A.
  • Haider A., Gooren LJ, Padungtod P., Saad F.. Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men. Andrologia. 2009;41: 713.
  • Hanley AJ, Karter AJ, Williams K., Festa A., D'Agostino RB Jr, Wagenknecht LE, Haffner SM. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation. 2005;112: 37133721.
  • Kalyani RR, Dobs AS. Androgen deficiency, diabetes, and the metabolic syndrome in men: current opinion in endocrinology, diabetes, and obesity. 2007;14: 226234.
  • Kapoor D., Clarke S., Stanworth R., Channer KS, Jones TH. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2007;156: 595602.
  • Kapoor D., Goodwin E., Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006;154: 899906.
  • Kenjo Y., Antoku Y., Akazawa K., Hanada E., Kinukawa N., Nose Y.. An easily customized, random allocation system using the minimization method for multi-institutional clinical trials. Comput Methods Programs Biomed. 2000;62: 4549.
  • Lanfranco F., Zitzmann M., Simoni M., Nieschlag E.. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin Endocrinol (Oxf). 2004;60: 500507.
  • Lee CH, Kuo SW, Hung YJ, Hsieh CH, He CT, Yang TC, Lian WC, Chyi-Fan S., Pei D.. The effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics. Endocr Res. 2005;31: 139148.
  • Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21: 21912192.
  • Muller M., Grobbee DE, den Tonkelaar I., Lamberts SW, van Der Schouw YT. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005;90: 26182623.
  • Pitteloud N., Mootha VK, Dwyer AA, Hardin M., Lee H., Eriksson KF, Tripathy D., Yialamas M., Groop L., Elahi D., Hayes FJ. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care. 2005;28: 16361642.
  • Resnick RH, Iber FL. Treatment of acute alcoholic hepatitis. Gut. 1972;13: 6873.
  • Smith MR, Lee H., Nathan DM. Insulin sensitivity during combined androgen blockade for prostate cancer. J Clin Endocrinol Metab. 2006;91: 13051308.
  • Stanworth RD, Jones TH. Testosterone in obesity, metabolic syndrome and type 2 diabetes. Front Horm Res. 2009;37: 7490.
  • Svartberg J.. Epidemiology: testosterone and the metabolic syndrome. Int J Impot Res. 2007;19: 124128.
  • Svartberg J., vo Muhlen D., Sundsfjord J., Jorde R.. Waist circumference and testosterone levels in community dwelling men: the Tromso study. Eur J Epidemiol. 2004;19: 657663.
  • Traish AM, Saad F., Guay A.. The dark side of testosterone deficiency: II: type 2 diabetes and insulin resistance. J Androl. 2009;30: 2332.
  • Yialamas MA, Dwyer AA, Hanley E., Lee H., Pitteloud N., Hayes FJ. Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2007;92: 42544259.
  • Zitzmann M., Faber S., Nieschlag E.. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab. 2006;91: 43354343.